Niagen Bioscience, Inc. (NAGE) Free cash flow 2016–2019
Niagen Bioscience, Inc. (NAGE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$21.2MFY2019 · since FY2016: -$4.4M → -$21.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | -$21.2M | +4.7% |
| FY2018 | -$22.2M | -102.6% |
| FY2017 | -$11.0M | -147.0% |
| FY2016 | -$4.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice